Oral film-coated tablet 20 mg

Each tablet contains 20 mg rivaroxaban

Pharmacologic category:

Anticoagulant, Factor Xa inhibitor, Direct Oral Anticoagulant (DOAC)

Indications:

Nonvalvular atrial fibrillation, deep vein thrombosis (DVT), pulmonary embolism (PE), reduction of risk of recurrent DVT or PE, prophylaxis of venous thromboembolism (VTE) in total knee or hip arthroplasty, prophylaxis of VTE in acutely ill medical patients, coronary artery disease (CAD), peripheral artery disease (PAD)